Background-Accelerated idioventricular rhythm (AIVR) or ventricular tachycardia (VT) originating from the right bundle branch (RBB) is rare and published clinical data on such arrhythmia are scarce. In this study, we will describe the clinical manifestations, diagnosis, and management of a cohort of patients with this novel arrhythmia. Methods and Results-Eight patients (5 men; median age, 25 years) with RBB-AIVR/VT were consecutively enrolled in the study. Pharmacological testing, exercise treadmill testing, electrophysiological study, and catheter ablation were performed in the study patients, and ECG features were characterized. All RBB-AIVR/VTs were of typical left bundle-branch block morphology with atrioventricular dissociation. The arrhythmias, which demonstrated chronotropic variability, were often isorhythmic with sinus rhythm and were accelerated by physical exercise, stress, and intravenous isoprenaline infusion. The rate of RBB-AIVR/VT varied from 45 to 200 beats per minute. Two patients experienced syncope, and 3 had impaired left ventricular function. Metoprolol was proven to be the most effective drug to decelerate the arrhythmia rate and relieve symptoms. Electrophysiology study was performed in 5 patients and the earliest activation with a sharp RBB potential was localized in the mid or distal RBB area. Catheter ablation terminated the arrhythmia with subsequent RBB block morphology during sinus rhythm. During follow-up, patients' symptoms were controlled with normalization of left ventricular function either on metoprolol or by catheter ablation. Conclusions-RBB-AIVR/VT is an unusual type of ventricular arrhythmia. It can result in significant symptoms and depressed ventricular function and can be successfully treated with catheter ablation. (Circ Arrhythm Electrophysiol.
A ccelerated idioventricular rhythm (AIVR) is traditionally defined as an ectopic rhythm with >3 consecutive premature beats, with gradual onset and gradual termination, and usually competitive with the sinus rhythm. 1 The rate of AIVR, usually <120 beats per minute, is normally faster than the usual ventricular intrinsic escape rate of 30 to 40 beats per minute, but slower than the rate of most ventricular tachycardias (VT). 1-3 AIVR, which is an uncommon ectopic rhythm, can sometimes be seen in infants or children and is regarded as a benign arrhythmia. 4 In adults, however, it is often transiently encountered in patients with acute myocardial infarction during the reperfusion period after thrombolysis, [5] [6] [7] or in the setting of postresuscitation, 8 digitalis intoxication, 9 or under anesthesia. 10, 11 In rare circumstances, AIVR can occur in patients with structurally normal hearts without any identifiable reasons and is regarded as truly idiopathic. Although the most common tachyarrhythmias from the left His-Purkinje system are intra-or interfascicular reentries or focal Purkinje VTs, 12 idiopathic AIVR in adult patients originating from the left His-Purkinje system and with benign clinical course has also been described. 13 On the right side, however, the most commonly reported AIVR activity is automatic originating from Mahaim fibers. [14] [15] [16] [17] Recently, several case reports have described focal VT or AIVR of right His-Purkinje system origin. [18] [19] [20] [21] There are, however, limited data on drug treatment and catheter ablation of AIVR in a large cohort of patients.
In this study, we describe 8 adult patients with idiopathic and persistent AIVR or VT originating from the right bundle branch or the moderator band area (RBB-AIVR/VT). The clinical course, ECG characteristics, drug therapy, and catheter ablation in such patients are also described.
Methods

Study Population
From September 2009 to January 2013, 8 consecutive patients with AIVR/VT of identical left bundle-branch block (LBBB) QRS morphology were included in the study. Their referral for clinical and electrophysiological assessments were because of persistent or intermittent AIVR/VT with or without symptoms recorded from surface ECG or Holter monitoring. Patient histories, routine testing such as echocardiography, and 24-hour Holter monitoring were acquired during hospitalization. After written informed consent, all patients agreed to undergo antiarrhythmic drug (AAD) testing, provocative drug testing, exercise stress testing, and electrophysiological study.
Provocative Drug Tests and Treadmill Stress Tests
AADs were discontinued for ≥5 half-lives before any testing was performed. The isoprenaline provocation test was performed while fasting and in supine position with defibrillator and intravenous AAD standby. The isoprenaline infusion was stopped in the following situations: when blood pressure increases >180/120 mm Hg or suddenly drops <90/60 mm Hg; and development of sustained ventricular arrhythmia. During isoprenaline provocation test, ECGs were recorded at baseline; isoprenaline, 1 to 4 μg/min; and every 2 minutes during the first 10 minutes of recovery and every 5 minutes during the following 20 minutes of recovery.
To confirm the influence of exercise on RBB-AIVR/VT, exercise stress testing was performed using the modified Bruce protocol using a treadmill system (General Electric), with defibrillator and intravenous AAD standby. The stress test was stopped when reaching the target heart rate or at the occurrence of sustained ventricular arrhythmias. During the stress test, ECGs were recorded at baseline, each minute during exercise, and each minute within the first 6 minutes of recovery.
The efficacy of AADs was evaluated by either reviewing the effect of previously used oral and intravenous AADs, or by direct assessment of the sensitivity of intravenous or oral AAD during hospitalization.
Electrophysiological Study
For patients with persistent AIVR/VT, an electrophysiological study and catheter ablation were performed under conscious sedation and local anesthesia. Venous access was obtained from the femoral veins. A decapolar catheter (Synaptic Ltd, Beijing, China) was placed at the His-RBB position in the right ventricle. A deflectable, quadripolar, open, irrigated-tip catheter (Navi-star, Biosense Webster) was inserted into the right ventricle for mapping and ablation. Endocardial activation maps were acquired during sinus rhythm, AIVR/VT, and atrial incremental pacing to identify the His-right bundle activation sequence and timing. Intracardiac electrograms were recorded using a digital electrophysiological recording system (Prucka CardioLab, General Electric Health Care System Inc, Milwaukee, WI or Bard Electrophysiology system, MA) and were filtered from 30 to 300 Hz.
Three-Dimensional Electroanatomic Mapping and Catheter Ablation
Detailed electroanatomic mapping of the right ventricle was performed by obtaining contact bipolar electrograms (100-150 points; the timing of the sampled electrogram was set at the onset of the ventricular electrogram or the RBB potential) during AIVR/VT guided by 3-dimensional (3D) electroanatomic mapping using a CARTO system (Biosense Webster Inc). Radiofrequency energy was delivered to the earliest activation point using an irrigated-tip catheter with a maximal temperature of 45°C, at a maximal power of 35 W, and at an infusion rate of 17 mL/min. The ablation end point was the noninducible termination of AIVR/VT during radiofrequency catheter ablation with and without drug provocation afterward.
Post Discharge Follow-Up
Antiarrhythmic agents were discontinued after a successful ablation procedure. In patients without ablation, AAD drug therapy was initiated. Regular outpatient follow-up visits were performed in all patients. A surface ECG and 24-hour Holter recording were performed after the procedure at 1 month and every 6 months thereafter. Furthermore, ECG or Holter recording was also performed at the time of any reported symptoms. Transthoracic echocardiography was also performed after the procedure at every 3 months during the followup period in patients with impaired left ventricular (LV) function. Patients who had a documented recurrence of persistent RBB-AIVR/ VT after ablation underwent the procedure again.
Statistical Analysis
Because of the small sample size of this study, the continuous variables were likely to be non-normally distributed. Therefore, these data were reported as median along with interquartile range (IQR).
Results
Patients Characteristics
Eight patients (5 men; median age, 25 years; IQR, 18-28), who were diagnosed with AIVR/VT originating from the RBB, were enrolled in the study (Table 1) . Palpitation was the most common symptom reported and was experienced by all patients. Two patients had a history of presyncope and syncope. The clinical arrhythmia was intermittent in 4 patients and persistent in 4 patients, respectively. Three of the 4 patients with persistent arrythmias developed exertional dyspnea and were noted to have impaired LV ejection fraction and an enlarged left ventricle. The estimated median (IQR) LV ejection fraction and LV end diastolic dimension were 64.1% (48.8-67.8) and 48 mm (46-57), respectively. The AIVR/VT burden was defined as the proportion of ectopic ventricular beats to the total number of QRS complexes during 24-hour Holter recording. Membranous ventricular septal aneurysm and right coronary Valsalva sinus aneurysm with mirror-image dextrocardia were detected by echocardiography and computed tomographic angiography in patient 8. None of the patients had a family history of heart disease or sudden cardiac death, and no patient had cardiac risk factors, such as hypertension or diabetes mellitus.
Features of the 12-Lead ECG
RBB-AIVR/VT in all patients demonstrated an identical LBBB QRS morphology in individual patient ( Figure 1 ; Table 1 ). The axis in the inferior leads was not fixed, but varied from patient to patient. The median (IQR) RS interval (between the initial deflection of r wave and the nadir of the S wave) was 50 ms (38-57) and the median (IQR) QRS width was 129 ms (112-144) in lead V1, with the precordial transition lead at V4 or V5.
On the basis of Holter recordings, 3 types of RBB-AIVR/VT behaviors were noted as follows (Table 1) : (1) persistent and dominant (AIVR/VT was the dominant rhythm with occasional sinus capture beats); (2) persistent and competitive (AIVR/VT is frequent and alternating or isorhythmic with sinus rhythm); and (3) intermittent and competitive (sinus rhythm is the dominant rhythm, competing with short runs of AIVR). Five patients were found to have an AIVR/VT burden of >20%.
Provocative Drug Tests and Stress Tests
Persistent AIVR/VT was noted to easily accelerate rate with greater extent during exercise, stress, and fever ( Figure 2 ). Patients with intermittent AIVR received isoprenaline provocative testing and treadmill stress testing. Acceleration of the arrhythmia rate was noticed during provocative testing, but it was competing with the sinus rhythm at a higher rate ( Figure 3 ). The rate variability of AIVR competing with sinus rhythm differed from patient to patient, but was normally suppressed by the latter when the sinus rate was >130 beats per minute.
Sensitivity of RBB-AIVR/VT to AAD and Cardioversion
The sensitivity of RBB-AIVR/VT to AAD in each patient is shown in Table 2 . Briefly, persistent RBB-AIVR/VT could be slowed but not terminated by intravenous amiodarone, propafenone, and metoprolol; and patients' symptoms were alleviated. However, these rhythms did not respond to during radiofrequency (RF) energy delivery. A sharp deflection preceded the earliest surface QRS by 32 ms. RF delivery quickly terminated the ectopic rhythm and the sinus beats are subsequently conducted with RBB block (RBBB) morphology. The fluoroscopic anterior-posterior (AP) view and the electroanatomic 3D map demonstrated the earliest activation was in the mid septal area of the right ventricle. C, AIVR/VT recurred with a RBBB pattern the second day after ablation. Minor change of QRS morphology of sinus capture was observed (circled in black), suggesting the site origin was slightly proximal to the previous ablation site (schematic representation). The slight different activation sequence of sinus capture contributes to the minor morphological changes of QRS complex. Please note the axis of the inferior leads was slightly shifted down, suggesting that sinus conducted beats captured the left fascicles a little bit earlier and activated the distal septum slightly faster compared with the RBB beats. AVN indicates atrioventricular node; LAF, left anterior fascicle; LPF, left posterior fascicle; HIS, HIS bundle; and RB, right bundle. December 2014 lidocaine and verapamil administration. In patient 1, who was hemodynamically unstable because of extremely rapid AIVR/ VT, external direct current cardioversion failed to terminate and, in fact, accelerated the tachycardia resulting in worsened clinical state. In patients with intermittent RBB-AIVR/VT, only propafenone, verapamil, and metoprolol were attempted. The burden of AIVR was reduced after oral administration of metoprolol, but seemed resistant to propafenone and verapamil. No complete suppression of AIVR was observed after drug therapy in the study patients. In patient 8, during recovering period after treadmill test, AIVR was transiently suppressed by 5 mg of intravenous metoprolol.
Electrophysiological Findings and Catheter Ablation
Five patients whose RBB-AIVR/VT was persistent or the burden was >20% underwent an electrophysiological study. Among them, 4 patients had simultaneous catheter ablation during the index procedure. Spontaneous AIVR/VT was observed at baseline with a median (IQR) cycle length of 620 ms (570-814) in all 5 patients. Bolus injection of ATP (20 mg) was administered in 3 patients with fast AIVR/VT, and although termination did not occur, AIVR/VT was overdriven by subsequent accelerated sinus rhythm transiently. Multipolar endocardial recordings during AIVR/VT showed a shortened His-bundle to ventricle (HV) interval, and RBB activation dramatically preceded the local ventricular electrogram, with right bundle activation in a retrograde pattern (Figures 4 and  5) . During sinus capture, however, the His-RBB activation proceeded in an antegrade pattern from proximal to distal activation. Atrial overdrive pacing could suppress AIVR/VT with narrow QRS and normal His-RBB conduction. A detailed electroanatomic 3D mapping was obtained during AIVR/VT in 4 patients. The earliest Purkinje potential was found in the mid or distal RBB area. Pacing mapping match scores at these points were poor. However, the delivery of radiofrequency energy at the earliest activation point immediately terminated AIVR/VT, and sinus rhythm was restored with RBB block morphology after termination of the arrythmia. The local Purkinje activation at the target area preceded the onset of surface QRS by a median (IQR) of 22 ms (18-32). Patient 8 had unsuccessful ablation because of challenging anatomy from dextrocardia with a membranous septal aneurysm and a right coronary Valsalva sinus aneurysm ( Figure 6 ). The large aneurysms prevented adequate catheter contact around the sites of earliest activation point within the RBB.
In patients 4 and 5, RBB-AIVR/VT recurred the second day after ablation, but with RBB block morphology ( Figure 4C) . A repeat procedure was performed and ablation was successful at a more proximal site within the RBB region. No complications occurred during and after the ablation procedures.
Follow-Up
All patients were treated with metoprolol after discharge except patient 2, and 3 patients had successful ablation. Patient 1, who declined a catheter ablation attempt for fear of conduction block, had a better rate control of AIVR/VT after oral metoprolol administration. However, 2 months after discharge, she died from complications of an unexplained and uncontrolled infection. In patient 2, whose AIVR burden was low, metoprolol was not used and she remained asymptomatic. In patient 6, the Figure 5 . Endocardial recordings of patient 5 during sinus rhythm, accelerated idioventricular rhythm (AIVR), atrial pacing, right ventricle (RV) mapping, and ablation. Tracings are surface lead I, aVF, V1, V2, and endocardial recordings from high right atrium (HRAd and HRAp), coronary sinus from proximal to distal, right bundle branch from proximal to distal, and mapping catheter (ABLd and ABLp). The activation sequence of HIS-RBB axis in sinus rhythm and atrial pacing was the same, whereas a reversed sequence was noticed during AIVR/ventricular tachycardia. Note that the septal ventricular electrogram during sinus rhythm recorded from the high-density mapping catheter showed 2 components. The solid arrow indicates the initial low-frequency electrogram, probably suggesting the far field signal from the left septum; the dashed arrow points to the latter high-frequency electrogram, suggesting the near field RV septum activation. The interesting finding was that the proximal right bundle branch (RBB) activation sequence remained unchanged after ablation with RBB block morphology, but the 2 components were slightly apart, suggesting the right septal myocardium was activated from the left side because of RBB block. reduction of AIVR burden was minor, but the symptoms were dramatically relieved by metoprolol medication. In patients 7 and 8, the AIVR burden was reduced by 8% and 22% on metoprolol, respectively. The impairment in LV function was completely reversed in 3 patients 6 months after successful ablation or treatment with metoprolol (LV ejection fraction: 60% in patient 3, 64% in patient 4, and 56% in patient 8).
Discussion
We describe an unusual type of ventricular arrhythmia (RBB-AIVR/VT), which should not be overlooked by cardiologists or electrophysiologists because of potentially insidious clinical results.
Clinical Manifestations and Potential Risks
As described in our study, RBB-AIVR/VT is generally idiopathic, and not associated with structural heart disease, except in 1 patient with dextrocardia and membranous septal and right coronary Valsalva sinus aneurysms. And, as in previous reports, there do not seem to be any clear predisposing factors for the development of such arrhythmias. [4] [5] [6] [7] [8] [9] [10] [11] RBB-AIVR/VT has chronotropic properties and is often isorhythmic with sinus rhythm. The behavior of this ectopic rhythm can be classified into 3 types as follows: persistent and dominant; persistent and competitive; intermittent and competitive. The prominent feature of this rhythm is that it is easily provoked by stress, physical exercise, or other clinical states, such as fever, anemia, or hypotension. The inappropriate acceleration of this ectopic rhythm can lead to rapid ventricular rates and resultant hemodynamic compromise. The most common symptom of this ventricular arrhythmia is palpitations, but more severe symptoms of presyncope, Adams-Stokes attacks, and dyspnea were also observed. Another adverse impact of this arrhythmia is tachycardia-induced cardiomyopathy in the setting of incessant arrhythmia or the higher burden of AIVR. The mechanism of this is similar to other ventricular tachyarrhythmia-related cardiomyopathy. 22, 23 In addition, because of its RBB origin, the ventricular activation mode is similar to that of LBBB and the inter-or intraventricular dyssynchrony might occur and could probably contribute to depressed ventricular function, 24 especially in those patients with high AIVR burden. Because of inappropriate acceleration and the potential possibility of developing arrhythmia-induced cardiomyopathy, it is important to emphasize that RBB-AIVR/VT should be treated vigorously either with drug or ablative therapy.
The ECG characteristics of RBB-AIVR/VT are distinct: typical LBBB morphology with sharp downstroke of the S wave and short rS duration (<70 ms) in precordial leads V1 and V2. The precordial transition is late, normally at V4 or V5. These features are consistent with initial ventricular activation via the His-Purkinje system. [25] [26] [27] The ventricular activation is faster than and dissociated with atrial activation. Although cardiac orientation has impact on the ECG morphology, the other important reason contributing to the slight morphological difference of the RBB-AIVR/VT among the study patients is its proximal or distal origin. The proximal RBB origin captures the left fascicle earlier by retrograde conduction, whereas the distal RBB origin propagates its activation more quickly over the myocardium of the interventricular septum to the left side.
Diagnosis and the Possible Mechanism
The ECG manifestations can strongly suggest that AIVR/VT is of RBB origin, but other diagnoses cannot be completely excluded. Junctional rhythm with LBBB, bundle branch reentry using the RBB in an antegrade fashion, or Mahaim fiber automaticity [14] [15] [16] [17] are all possibilities. However, endocardial recordings and pacing maneuvers can distinguish these types of arrhythmias. Multipolar endocardial recordings along with the His-RBB axis clearly demonstrated that the HV was short and the RBB potential was markedly earlier than local ventricular activation, and activated in a retrograde direction. During sinus or atrial capture beats, the RBB activation direction was reversed. Similar findings were also presented in previously reported case studies. [18] [19] [20] [21] This activation sequence of the RBB ruled out the possibility of bundle branch reentry or junctional rhythm with LBBB because these rhythms should have an antegrade RBB activation pattern. Also, a sharp, low-amplitude, high-frequency (mahaim-like) potentials were not found to precede the local ventricular activation around the tricuspid annulus. Therefore, automaticity from the atriofascicular fiber can be excluded in the 5 patients with invasive procedure. Furthermore, junctional focus should have an identical HV interval to that of the sinus rhythm, whereas bundle branch reentry usually has a longer HV interval. Successful ablation at the site of earliest RBB potential activation eliminated the arrhythmia with subsequent sinus rhythm and RBB block morphology, supporting that these rhythms are of RBB origin, either from the proximal or distal area (moderator band). Incremental atrial pacing could also overdrive the ventricle with subsequent narrow QRS complex and HV normalization, which excluded the presence of Mahaim fibers.
The likely mechanism of RBB-AIVR/VT seems to be increased automaticity because of its focal origin and its chronotropic response, yet the underlying reason why it occurs remains unknown and needs further study.
Management
As shown in our study, RBB-AIVR/VT was not truly benign; therefore, this arrhythmia should be appropriately treated. On the basis of AAD use in our patients, β-blocker should be the first line drug therapy for treatment of RBB-AIVR/VT. It can adequately slow RBB-AIVR/VT, subsequently relieve symptoms, and improve the hemodynamic state. Furthermore, β-blocker therapy can also reduce the AIVR burden or even terminate AIVR in some patients. For persistent or incessant RBB-AIVR/VT, amiodarone or propafenone could also be used intravenously to slow the rate. In emergencies, however, electric cardioversion was ineffective, whereas intravenous sedation or even general anesthesia may be necessary with simultaneous proper AAD therapy. Lidocaine and verapamil were of no use for such arrhythmias and therefore should be avoided.
Catheter ablation is a good option for arrhythmia treatment in such patients. In this study, patients who underwent ablation were those who experienced presyncope or syncope, who had an arrhythmia burden of >20% on Holter monitoring, and those with concomitant cardiomyopathy.
Study Limitations
Entrainment pacing was not performed in all patients undergoing electrophysiological study. Therefore, a potential reentrant mechanism cannot be entirely excluded. This is similar to the case of fascicular VTs encountered on the left side where entrainment pacing may not always be possible. Also, atrial and ventricular programmed stimulation to construct a resetting curve were not done to depict the responses of this focal activation to the extra stimuli. Such stimulation should be done in the future cases.
Intracardiac echo was not used to confirm the anatomic location of the origin of RBB-AIVR/VT. However, the target electrogram, 3D map, and the fluoroscopy were the strong references for the location. Only 1 case (patient 3) may have been from distal RBB or the moderator band origin (see the Data Supplement).
Exercise testing and provocative drug testing were not performed in all patients.
Finally, the anatomic location and mechanism were inferred from the ECG findings in 3 patients without electrophysiological study.
Conclusions
RBB-AIVR/VT is an unusual form of ventricular arrhythmia. Although the clinical presentation may be relatively benign, a tendency toward more rapid ventricular rates and higher arrhythmia burden can worsen the clinical course. β-blockers are an effective drug therapy to alleviate clinical symptoms, and catheter ablation is a good option for an ultimate cure for such arrhythmias.
